Industry Research Reports

Home > Reports > Chemical & Material > Global NSAID API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global NSAID API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Chemical & Material

Published Date: 2025-02-24

Pages: 91 Pages

Report ld: 4198131

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global NSAID API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.

North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.

The global NSAID API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global NSAID API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

MARKET SEGMENTATION

By Company

Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
BASF
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Cambrex
Dr. Reddy's Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Paracetamol
Ibuprofen
Aspirin
Naproxen
Others

Segment by Application

Captive Manufacturing
Contract Manufacturing

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales and revenue of NSAID API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.

Chapter 3: Detailed analysis of NSAID API manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NSAID API revenue, gross margin, and recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Sales channels analysis

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 NSAID API Product Scope

1.2 NSAID API by Type

1.2.1 Global NSAID API Sales by Type (2020 & 2024 & 2031)

1.2.2 Paracetamol

1.2.3 Ibuprofen

1.2.4 Aspirin

1.2.5 Naproxen

1.2.6 Others

1.3 NSAID API by Application

1.3.1 Global NSAID API Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Captive Manufacturing

1.3.3 Contract Manufacturing

1.4 Global NSAID API Market Estimates and Forecasts (2020-2031)

1.4.1 Global NSAID API Market Size in Value Growth Rate (2020-2031)

1.4.2 Global NSAID API Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global NSAID API Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global NSAID API Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global NSAID API Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global NSAID API Sales Market Share by Region (2020-2025)

2.2.2 Global NSAID API Revenue Market Share by Region (2020-2025)

2.3 Global NSAID API Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global NSAID API Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global NSAID API Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America NSAID API Market Size and Prospective (2020-2031)

2.4.2 Europe NSAID API Market Size and Prospective (2020-2031)

2.4.3 China NSAID API Market Size and Prospective (2020-2031)

2.4.4 Japan NSAID API Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global NSAID API Historic Market Review by Type (2020-2025)

3.1.1 Global NSAID API Sales by Type (2020-2025)

3.1.2 Global NSAID API Revenue by Type (2020-2025)

3.1.3 Global NSAID API Price by Type (2020-2025)

3.2 Global NSAID API Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global NSAID API Sales Forecast by Type (2026-2031)

3.2.2 Global NSAID API Revenue Forecast by Type (2026-2031)

3.2.3 Global NSAID API Price Forecast by Type (2026-2031)

3.3 Different Types NSAID API Representative Players

4 Global Market Size by Application

4.1 Global NSAID API Historic Market Review by Application (2020-2025)

4.1.1 Global NSAID API Sales by Application (2020-2025)

4.1.2 Global NSAID API Revenue by Application (2020-2025)

4.1.3 Global NSAID API Price by Application (2020-2025)

4.2 Global NSAID API Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global NSAID API Sales Forecast by Application (2026-2031)

4.2.2 Global NSAID API Revenue Forecast by Application (2026-2031)

4.2.3 Global NSAID API Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in NSAID API Application

5 Competition Landscape by Players

5.1 Global NSAID API Sales by Players (2020-2025)

5.2 Global Top NSAID API Players by Revenue (2020-2025)

5.3 Global NSAID API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAID API as of 2024)

5.4 Global NSAID API Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of NSAID API, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of NSAID API, Product Type & Application

5.7 Global Key Manufacturers of NSAID API, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America NSAID API Sales by Company

6.1.1.1 North America NSAID API Sales by Company (2020-2025)

6.1.1.2 North America NSAID API Revenue by Company (2020-2025)

6.1.2 North America NSAID API Sales Breakdown by Type (2020-2025)

6.1.3 North America NSAID API Sales Breakdown by Application (2020-2025)

6.1.4 North America NSAID API Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe NSAID API Sales by Company

6.2.1.1 Europe NSAID API Sales by Company (2020-2025)

6.2.1.2 Europe NSAID API Revenue by Company (2020-2025)

6.2.2 Europe NSAID API Sales Breakdown by Type (2020-2025)

6.2.3 Europe NSAID API Sales Breakdown by Application (2020-2025)

6.2.4 Europe NSAID API Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China NSAID API Sales by Company

6.3.1.1 China NSAID API Sales by Company (2020-2025)

6.3.1.2 China NSAID API Revenue by Company (2020-2025)

6.3.2 China NSAID API Sales Breakdown by Type (2020-2025)

6.3.3 China NSAID API Sales Breakdown by Application (2020-2025)

6.3.4 China NSAID API Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan NSAID API Sales by Company

6.4.1.1 Japan NSAID API Sales by Company (2020-2025)

6.4.1.2 Japan NSAID API Revenue by Company (2020-2025)

6.4.2 Japan NSAID API Sales Breakdown by Type (2020-2025)

6.4.3 Japan NSAID API Sales Breakdown by Application (2020-2025)

6.4.4 Japan NSAID API Major Customer

6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Novartis

7.1.1 Novartis Company Information

7.1.2 Novartis Business Overview

7.1.3 Novartis NSAID API Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Novartis NSAID API Products Offered

7.1.5 Novartis Recent Development

7.2 Pfizer

7.2.1 Pfizer Company Information

7.2.2 Pfizer Business Overview

7.2.3 Pfizer NSAID API Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Pfizer NSAID API Products Offered

7.2.5 Pfizer Recent Development

7.3 Boehringer Ingelheim

7.3.1 Boehringer Ingelheim Company Information

7.3.2 Boehringer Ingelheim Business Overview

7.3.3 Boehringer Ingelheim NSAID API Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Boehringer Ingelheim NSAID API Products Offered

7.3.5 Boehringer Ingelheim Recent Development

7.4 Teva Pharmaceutical

7.4.1 Teva Pharmaceutical Company Information

7.4.2 Teva Pharmaceutical Business Overview

7.4.3 Teva Pharmaceutical NSAID API Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Teva Pharmaceutical NSAID API Products Offered

7.4.5 Teva Pharmaceutical Recent Development

7.5 BASF

7.5.1 BASF Company Information

7.5.2 BASF Business Overview

7.5.3 BASF NSAID API Sales, Revenue and Gross Margin (2020-2025)

7.5.4 BASF NSAID API Products Offered

7.5.5 BASF Recent Development

7.6 Hospira

7.6.1 Hospira Company Information

7.6.2 Hospira Business Overview

7.6.3 Hospira NSAID API Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Hospira NSAID API Products Offered

7.6.5 Hospira Recent Development

7.7 Lonza Group

7.7.1 Lonza Group Company Information

7.7.2 Lonza Group Business Overview

7.7.3 Lonza Group NSAID API Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Lonza Group NSAID API Products Offered

7.7.5 Lonza Group Recent Development

7.8 Mylan

7.8.1 Mylan Company Information

7.8.2 Mylan Business Overview

7.8.3 Mylan NSAID API Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Mylan NSAID API Products Offered

7.8.5 Mylan Recent Development

7.9 Aurobindo Pharma

7.9.1 Aurobindo Pharma Company Information

7.9.2 Aurobindo Pharma Business Overview

7.9.3 Aurobindo Pharma NSAID API Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Aurobindo Pharma NSAID API Products Offered

7.9.5 Aurobindo Pharma Recent Development

7.10 Cambrex

7.10.1 Cambrex Company Information

7.10.2 Cambrex Business Overview

7.10.3 Cambrex NSAID API Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Cambrex NSAID API Products Offered

7.10.5 Cambrex Recent Development

7.11 Dr. Reddy's Laboratories

7.11.1 Dr. Reddy's Laboratories Company Information

7.11.2 Dr. Reddy's Laboratories Business Overview

7.11.3 Dr. Reddy's Laboratories NSAID API Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Dr. Reddy's Laboratories NSAID API Products Offered

7.11.5 Dr. Reddy's Laboratories Recent Development

7.12 Actavis

7.12.1 Actavis Company Information

7.12.2 Actavis Business Overview

7.12.3 Actavis NSAID API Sales, Revenue and Gross Margin (2020-2025)

7.12.4 Actavis NSAID API Products Offered

7.12.5 Actavis Recent Development

7.13 Wuxi Apptec

7.13.1 Wuxi Apptec Company Information

7.13.2 Wuxi Apptec Business Overview

7.13.3 Wuxi Apptec NSAID API Sales, Revenue and Gross Margin (2020-2025)

7.13.4 Wuxi Apptec NSAID API Products Offered

7.13.5 Wuxi Apptec Recent Development

7.14 Zhejiang NHU

7.14.1 Zhejiang NHU Company Information

7.14.2 Zhejiang NHU Business Overview

7.14.3 Zhejiang NHU NSAID API Sales, Revenue and Gross Margin (2020-2025)

7.14.4 Zhejiang NHU NSAID API Products Offered

7.14.5 Zhejiang NHU Recent Development

8 NSAID API Manufacturing Cost Analysis

8.1 NSAID API Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of NSAID API

8.4 NSAID API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 NSAID API Distributors List

9.3 NSAID API Customers

10 NSAID API Market Dynamics

10.1 NSAID API Industry Trends

10.2 NSAID API Market Drivers

10.3 NSAID API Market Challenges

10.4 NSAID API Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global NSAID API Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global NSAID API Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market NSAID API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global NSAID API Sales (K MT) by Region (2020-2025)

Table 5. Global NSAID API Sales Market Share by Region (2020-2025)

Table 6. Global NSAID API Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global NSAID API Revenue Share by Region (2020-2025)

Table 8. Global NSAID API Sales (K MT) Forecast by Region (2026-2031)

Table 9. Global NSAID API Sales Market Share Forecast by Region (2026-2031)

Table 10. Global NSAID API Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global NSAID API Revenue Share Forecast by Region (2026-2031)

Table 12. Global NSAID API Sales by Type (K MT) & (2020-2025)

Table 13. Global NSAID API Sales Share by Type (2020-2025)

Table 14. Global NSAID API Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global NSAID API Price by Type (USD/MT) & (2020-2025)

Table 16. Global NSAID API Sales by Type (K MT) & (2026-2031)

Table 17. Global NSAID API Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global NSAID API Price by Type (USD/MT) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global NSAID API Sales by Application (K MT) & (2020-2025)

Table 21. Global NSAID API Sales Share by Application (2020-2025)

Table 22. Global NSAID API Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global NSAID API Price by Application (USD/MT) & (2020-2025)

Table 24. Global NSAID API Sales by Application (K MT) & (2026-2031)

Table 25. Global NSAID API Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global NSAID API Price by Application (USD/MT) & (2026-2031)

Table 27. New Sources of Growth in NSAID API Application

Table 28. Global NSAID API Sales by Company (K MT) & (2020-2025)

Table 29. Global NSAID API Sales Share by Company (2020-2025)

Table 30. Global NSAID API Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global NSAID API Revenue Share by Company (2020-2025)

Table 32. Global NSAID API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAID API as of 2024)

Table 33. Global Market NSAID API Average Price by Company (USD/MT) & (2020-2025)

Table 34. Global Key Manufacturers of NSAID API, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of NSAID API, Product Type & Application

Table 36. Global Key Manufacturers of NSAID API, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America NSAID API Sales by Company (2020-2025) & (K MT)

Table 39. North America NSAID API Sales Market Share by Company (2020-2025)

Table 40. North America NSAID API Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America NSAID API Revenue Market Share by Company (2020-2025)

Table 42. North America NSAID API Sales by Type (2020-2025) & (K MT)

Table 43. North America NSAID API Sales Market Share by Type (2020-2025)

Table 44. North America NSAID API Sales by Application (2020-2025) & (K MT)

Table 45. North America NSAID API Sales Market Share by Application (2020-2025)

Table 46. Europe NSAID API Sales by Company (2020-2025) & (K MT)

Table 47. Europe NSAID API Sales Market Share by Company (2020-2025)

Table 48. Europe NSAID API Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe NSAID API Revenue Market Share by Company (2020-2025)

Table 50. Europe NSAID API Sales by Type (2020-2025) & (K MT)

Table 51. Europe NSAID API Sales Market Share by Type (2020-2025)

Table 52. Europe NSAID API Sales by Application (2020-2025) & (K MT)

Table 53. Europe NSAID API Sales Market Share by Application (2020-2025)

Table 54. China NSAID API Sales by Company (2020-2025) & (K MT)

Table 55. China NSAID API Sales Market Share by Company (2020-2025)

Table 56. China NSAID API Revenue by Company (2020-2025) & (US$ Million)

Table 57. China NSAID API Revenue Market Share by Company (2020-2025)

Table 58. China NSAID API Sales by Type (2020-2025) & (K MT)

Table 59. China NSAID API Sales Market Share by Type (2020-2025)

Table 60. China NSAID API Sales by Application (2020-2025) & (K MT)

Table 61. China NSAID API Sales Market Share by Application (2020-2025)

Table 62. Japan NSAID API Sales by Company (2020-2025) & (K MT)

Table 63. Japan NSAID API Sales Market Share by Company (2020-2025)

Table 64. Japan NSAID API Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan NSAID API Revenue Market Share by Company (2020-2025)

Table 66. Japan NSAID API Sales by Type (2020-2025) & (K MT)

Table 67. Japan NSAID API Sales Market Share by Type (2020-2025)

Table 68. Japan NSAID API Sales by Application (2020-2025) & (K MT)

Table 69. Japan NSAID API Sales Market Share by Application (2020-2025)

Table 70. Novartis Company Information

Table 71. Novartis Description and Business Overview

Table 72. Novartis NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 73. Novartis NSAID API Product

Table 74. Novartis Recent Development

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 78. Pfizer NSAID API Product

Table 79. Pfizer Recent Development

Table 80. Boehringer Ingelheim Company Information

Table 81. Boehringer Ingelheim Description and Business Overview

Table 82. Boehringer Ingelheim NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 83. Boehringer Ingelheim NSAID API Product

Table 84. Boehringer Ingelheim Recent Development

Table 85. Teva Pharmaceutical Company Information

Table 86. Teva Pharmaceutical Description and Business Overview

Table 87. Teva Pharmaceutical NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 88. Teva Pharmaceutical NSAID API Product

Table 89. Teva Pharmaceutical Recent Development

Table 90. BASF Company Information

Table 91. BASF Description and Business Overview

Table 92. BASF NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 93. BASF NSAID API Product

Table 94. BASF Recent Development

Table 95. Hospira Company Information

Table 96. Hospira Description and Business Overview

Table 97. Hospira NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 98. Hospira NSAID API Product

Table 99. Hospira Recent Development

Table 100. Lonza Group Company Information

Table 101. Lonza Group Description and Business Overview

Table 102. Lonza Group NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 103. Lonza Group NSAID API Product

Table 104. Lonza Group Recent Development

Table 105. Mylan Company Information

Table 106. Mylan Description and Business Overview

Table 107. Mylan NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 108. Mylan NSAID API Product

Table 109. Mylan Recent Development

Table 110. Aurobindo Pharma Company Information

Table 111. Aurobindo Pharma Description and Business Overview

Table 112. Aurobindo Pharma NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 113. Aurobindo Pharma NSAID API Product

Table 114. Aurobindo Pharma Recent Development

Table 115. Cambrex Company Information

Table 116. Cambrex Description and Business Overview

Table 117. Cambrex NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 118. Cambrex NSAID API Product

Table 119. Cambrex Recent Development

Table 120. Dr. Reddy's Laboratories Company Information

Table 121. Dr. Reddy's Laboratories Description and Business Overview

Table 122. Dr. Reddy's Laboratories NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 123. Dr. Reddy's Laboratories NSAID API Product

Table 124. Dr. Reddy's Laboratories Recent Development

Table 125. Actavis Company Information

Table 126. Actavis Description and Business Overview

Table 127. Actavis NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 128. Actavis NSAID API Product

Table 129. Actavis Recent Development

Table 130. Wuxi Apptec Company Information

Table 131. Wuxi Apptec Description and Business Overview

Table 132. Wuxi Apptec NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 133. Wuxi Apptec NSAID API Product

Table 134. Wuxi Apptec Recent Development

Table 135. Zhejiang NHU Company Information

Table 136. Zhejiang NHU Description and Business Overview

Table 137. Zhejiang NHU NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 138. Zhejiang NHU NSAID API Product

Table 139. Zhejiang NHU Recent Development

Table 140. Production Base and Market Concentration Rate of Raw Material

Table 141. Key Suppliers of Raw Materials

Table 142. NSAID API Distributors List

Table 143. NSAID API Customers List

Table 144. NSAID API Market Trends

Table 145. NSAID API Market Drivers

Table 146. NSAID API Market Challenges

Table 147. NSAID API Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. NSAID API Product Picture

Figure 2. Global NSAID API Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global NSAID API Sales Market Share by Type in 2024 & 2031

Figure 4. Paracetamol Product Picture

Figure 5. Ibuprofen Product Picture

Figure 6. Aspirin Product Picture

Figure 7. Naproxen Product Picture

Figure 8. Others Product Picture

Figure 9. Global NSAID API Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 10. Global NSAID API Sales Market Share by Application in 2024 & 2031

Figure 11. Captive Manufacturing Examples

Figure 12. Contract Manufacturing Examples

Figure 13. Global NSAID API Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global NSAID API Sales Growth Rate (2020-2031) & (US$ Million)

Figure 15. Global NSAID API Sales (K MT) Growth Rate (2020-2031)

Figure 16. Global NSAID API Price Trends Growth Rate (2020-2031) & (USD/MT)

Figure 17. NSAID API Report Years Considered

Figure 18. Global Market NSAID API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 19. Global NSAID API Revenue Market Share by Region: 2020 VS 2024

Figure 20. North America NSAID API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. North America NSAID API Sales (K MT) Growth Rate (2020-2031)

Figure 22. Europe NSAID API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. Europe NSAID API Sales (K MT) Growth Rate (2020-2031)

Figure 24. China NSAID API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. China NSAID API Sales (K MT) Growth Rate (2020-2031)

Figure 26. Japan NSAID API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 27. Japan NSAID API Sales (K MT) Growth Rate (2020-2031)

Figure 28. Global NSAID API Revenue Share by Type (2020-2025)

Figure 29. Global NSAID API Sales Share by Type (2026-2031)

Figure 30. Global NSAID API Revenue Share by Type (2026-2031)

Figure 31. Global NSAID API Revenue Share by Application (2020-2025)

Figure 32. Global NSAID API Revenue Growth Rate by Application in 2020 & 2024

Figure 33. Global NSAID API Sales Share by Application (2026-2031)

Figure 34. Global NSAID API Revenue Share by Application (2026-2031)

Figure 35. Global NSAID API Sales Share by Company (2024)

Figure 36. Global NSAID API Revenue Share by Company (2024)

Figure 37. Global 5 Largest NSAID API Players Market Share by Revenue in NSAID API: 2020 & 2024

Figure 38. NSAID API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 39. Manufacturing Cost Structure of NSAID API

Figure 40. Manufacturing Process Analysis of NSAID API

Figure 41. NSAID API Industrial Chain

Figure 42. Channels of Distribution (Direct Vs Distribution)

Figure 43. Distributors Profiles

Figure 44. Bottom-up and Top-down Approaches for This Report

Figure 45. Data Triangulation

Figure 46. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global NSAID API market? zhanKai

The top companies in the global NSAID API market are Novartis、Pfizer、Boehringer Ingelheim.

Related Reports

NSAID API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for NSAID API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 141
USD 3950.00
(Single User License)
Global NSAID API Market Research Report 2026
The global NSAID API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 136
USD 2900.00
(Single User License)
Global NSAID API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global NSAID API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 158
USD 4900.00
(Single User License)
Global NSAID API Market Research Report 2025
The global market for NSAID API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 101
USD 2900.00
(Single User License)
NSAID API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for NSAID API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 119
USD 3950.00
(Single User License)
Global NSAID API Market Insights, Forecast to 2030
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.
Published Date: 2024-04-22
Pages: 109
USD 4900.00
(Single User License)
Global NSAID API Market Research Report 2024
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.
Published Date: 2024-01-16
Pages: 101
USD 2900.00
(Single User License)

NSAID API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for NSAID API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 141
USD 3950.00 (Single User License)
Global NSAID API Market Research Report 2026
The global NSAID API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 136
USD 2900.00 (Single User License)
Global NSAID API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global NSAID API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 158
USD 4900.00 (Single User License)
Global NSAID API Market Research Report 2025
The global market for NSAID API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 101
USD 2900.00 (Single User License)
NSAID API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for NSAID API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 119
USD 3950.00 (Single User License)
Global NSAID API Market Insights, Forecast to 2030
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.
Published: 2024-04-22
Pages: 109
USD 4900.00 (Single User License)
Global NSAID API Market Research Report 2024
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.
Published: 2024-01-16
Pages: 101
USD 2900.00 (Single User License)